D. Adachi

Two common founder mutations of the fanconi anemia group g gene FANCG/XRCC9 in the Japanese population

T. Nakajima, S. Asano, T. Nakahata, 2003, Human mutation.

p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.

Y. Ung, J. Howard, Y. Ben-David, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia

S. Asano, A. Tojo, K. Tani, 2002, Annals of Hematology.

Signal Transduction (1930 articles)

A. D’Andrea, S. Asano, I. Garcı́a-Higuera, 2013 .

A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA.

A. D’Andrea, S. Asano, I. Garcı́a-Higuera, 2001, Blood.

Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.

J. Trent, R. Kerbel, J. Rak, 1996, Cancer research.

Retroviral insertional mutagenesis as a strategy for the identification of genes associated with cis-diamminedichloroplatinum(II) resistance.

R. Kerbel, S. Man, Y. Ben-David, 1995, Cancer research.

Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.

A. D’Andrea, S. Asano, T. Taniguchi, 2002, Human molecular genetics.

Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma.

S. Asano, A. Tojo, K. Tani, 2001, Haematologica.

Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells

H. Akaza, R. Mulligan, S. Asano, 2000, Cancer Chemotherapy and Pharmacology.